Financials in USD. Standardized financial statements.
A compact view of how Torii Pharmaceutical Co., Ltd. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $60.42B | $54.64B | $48.89B | $46.99B | $41.70B | $43.00B | $62.55B | $64.13B | $60.21B | $62.38B |
| Revenue Growth? | +10.6% | +11.7% | +4.1% | +12.7% | -3.0% | -31.3% | -2.5% | +6.5% | -3.5% | 0.0% |
| Cost of Revenue? | $33.72B | $31.88B | $25.52B | $22.65B | $19.96B | $20.70B | $31.84B | $31.29B | $30.29B | $30.81B |
| Gross Profit? | $26.71B | $22.76B | $23.38B | $24.34B | $21.74B | $22.30B | $30.71B | $32.84B | $29.92B | $31.56B |
| Gross Margin? | +44.2% | +41.7% | +47.8% | +51.8% | +52.1% | +51.9% | +49.1% | +51.2% | +49.7% | +50.6% |
| Operating Expenses? | $19.91B | $17.72B | $17.84B | $19.68B | $17.00B | $20.86B | $25.75B | $26.56B | $26.10B | $26.64B |
| Operating Income? | $6.80B | $5.04B | $5.54B | $4.66B | $4.74B | $1.43B | $4.95B | $6.28B | $3.82B | $4.92B |
| EBITDA? | $7.13B | $6.05B | $5.97B | $5.05B | $4.69B | $38.51B | $3.88B | $7.46B | $5.24B | $6.38B |
| Income Before Tax | $6.72B | $5.59B | $5.72B | $4.77B | $4.22B | $37.70B | $3.03B | $6.37B | $4.06B | $5.26B |
| Income Tax Expense | $1.68B | $1.47B | $1.78B | $1.39B | $729.00M | $10.33B | $1.86B | $1.66B | $1.22B | $1.73B |
| Net Income? | $5.04B | $4.12B | $3.94B | $3.37B | $3.50B | $27.37B | $1.16B | $4.72B | $2.84B | $3.53B |
| EPS? | $179.46 | $146.57 | $140.38 | $120.11 | $124.47 | $974.99 | $41.49 | $168.22 | $100.41 | $124.65 |
| Diluted EPS? | $179.46 | $146.57 | $140.38 | $120.11 | $124.46 | $974.99 | $41.49 | $168.22 | $100.41 | $124.65 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality